Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLERIXAFOR for Haematopoietic stem cell mobilisation: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 151 adverse event reports in the FDA FAERS database where PLERIXAFOR was used for Haematopoietic stem cell mobilisation.

Most Reported Side Effects for PLERIXAFOR

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 69 15.4% 13 18
Mucosal inflammation 47 10.5% 6 3
Nausea 29 6.5% 2 11
Off label use 29 6.5% 4 4
Dyspnoea 28 6.3% 1 19
Pyrexia 27 6.0% 6 16
Diarrhoea 24 5.4% 7 6
Thrombocytopenia 23 5.2% 2 6
Acute kidney injury 21 4.7% 2 18
Acute respiratory distress syndrome 20 4.5% 3 17
Escherichia infection 18 4.0% 6 11
Alanine aminotransferase increased 17 3.8% 1 16
Colitis 17 3.8% 0 16
Herpes simplex 17 3.8% 3 0
Stomatitis 17 3.8% 1 2

Other Indications for PLERIXAFOR

Plasma cell myeloma (30) Bone marrow conditioning regimen (21) Diffuse large b-cell lymphoma (17) Product used for unknown indication (17) Transplant (16) Acute myeloid leukaemia (13) Stem cell transplant (11) Non-hodgkin's lymphoma (9) Peripheral blood stem cell apheresis (9) Combined immunodeficiency (8)

Other Drugs Used for Haematopoietic stem cell mobilisation

FILGRASTIM (988) CYCLOPHOSPHAMIDE (254) PEGFILGRASTIM (109) ETOPOSIDE (56) GRANULOCYTE COLONY-STIMULATING FACTOR NOS (51) CYTARABINE (23) LENOGRASTIM (22) BUSULFAN (18) DEXAMETHASONE (18) FLUDARABINE (16)

Related Pages

PLERIXAFOR Full Profile All Haematopoietic stem cell mobilisation Drugs PLERIXAFOR Demographics PLERIXAFOR Timeline